TickerGuard
Buy Day today: Neutral (50) Mixed market breadth · no major macro event
PRGO

Perrigo Company PLC

Healthcare · Drug Manufacturers - Specialty & Generic

12.80$ -1.7% vs. previous close Closing price · As of: Aug 17, 2026

Statements

Segments

US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Perrigo Company PLC (PRGO). It shows which part of the business is growing — and which one is holding it back.

Revenue by business segment

Revenue by business segment — PRGO
Segment 2020 2021 2022 2023 2024 2025
CSCA $2.69B 65.9% $2.69B 65.1% · +0.0% $2.93B 65.7% · +8.6% $2.96B 63.6% · +1.2% $2.69B 61.6% · -9.1% $2.59B 60.8% · -4.0%
CSCI $1.40B 34.1% $1.45B 34.9% · +3.6% $1.53B 34.3% · +5.5% $1.69B 36.4% · +11.0% $1.68B 38.4% · -0.8% $1.67B 39.2% · -0.7%
RX Pharmaceuticals $0 0.0% $0 0.0%

Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.

Operating income — PRGO
Segment 2020 2021 2022 2023 2024 2025
CSCA
CSCI
RX Pharmaceuticals $0 $0

Large figure: segment operating income. Below it the margin, that is operating income measured against the revenue of the same segment.

Revenue by region

Revenue by region — PRGO
Segment 2020 2021 2022 2023 2024 2025
United States $2.58B 62.6% $2.57B 61.6% · -0.5% $2.87B 64.0% · +11.9% $2.92B 62.1% · +1.6% $2.65B 60.0% · -9.2% $2.54B 59.1% · -4.1%
Europe $1.35B 32.8% $1.39B 33.5% · +3.1% $1.47B 32.9% · +5.8% $1.62B 34.5% · +10.1% $1.60B 36.4% · -1.1% $1.62B 37.6% · +0.7%
All other countries $158.6M 3.9% $179.8M 4.3% · +13.4% $107.3M 2.4% · -40.3% $116.3M 2.5% · +8.4% $119.5M 2.7% · +2.8% $96.7M 2.3% · -19.1%
Ireland $29.8M 0.7% $23.7M 0.6% · -20.5% $29.3M 0.7% · +23.6% $40.8M 0.9% · +39.2% $39.6M 0.9% · -2.9% $42.1M 1.0% · +6.3%

Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.

Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.

Data as of: August 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?